SARS-CoV-2

AI | Bioinformatics | COVID-19 | Drug Discovery | LLM | News | Paper Summary | Trending

Exploring New Frontiers in SARS-CoV-2 Research with The Virtual Lab
ByAnchal Negi November 28, 2024October 22, 2026

When COVID-19 emerged as a global catastrophe, the scientists had only one goal: to come up with the possible treatments for the virus SARS-CoV-2, which was quickly changing its form. Now, scientists appear to be harnessing the potential of artificial intelligence (AI) to explore unexplored territories in science. One such approach introduced by Stanford University…

Read More Exploring New Frontiers in SARS-CoV-2 Research with The Virtual Lab
Covid-19 News | Health | Infectious Diseases | News | Paper Summary | SARS-CoV-2 | Trending | Virus

Long COVID: Understanding the Lingering Effects of COVID-19
ByAnchal Negi August 12, 2024October 22, 2026

The COVID-19 pandemic has undoubtedly caused a lasting impact on the world. Millions of people worldwide are still struggling with the aftermath of COVID-19, which is increasingly referred to as Long COVID. Healthcare professionals and scientists across the globe are increasingly worried about this complex syndrome. The scale and intricacy of this post-viral condition have…

Read More Long COVID: Understanding the Lingering Effects of COVID-19
Bioinformatics | Covid-19 News | Drug Discovery | Infectious Diseases | News | Paper Summary | Trending | Virus

The Rise of mRNA Vaccines: A Game-Changer for Public Health?
BySwasti Tyagi October 9, 2023January 25, 2024

The emergence of mRNA vaccine technology represents a monumental leap forward in disease prevention. A review article published in Nature Reviews Drug Discovery by researchers at the University of Pennsylvania and Carnegie Mellon University discusses the evolution of messenger RNA (mRNA) based vaccines over the course of the past few years. The powerful effects of…

Read More The Rise of mRNA Vaccines: A Game-Changer for Public Health?
AI | Bioinformatics | COVID-19 | Covid-19 News | Drug Discovery | News | Paper Summary | SARS-CoV-2 | Structural Biology | Tools | Trending

Brock Researchers Develop AI-Powered Tool ‘DAPTEV’ to Design New Aptamer Drugs for COVID-19
ByNeegar Naushaba Iqbal August 5, 2023October 22, 2026

Traditional drug discovery and development methods are quite expensive, cumbersome, and prone to the biases of experts. A revolution in the field of drug development has emerged in the form of aptamers. Aptamers are single-stranded oligonucleotides (DNA/RNA) capable of binding to biomolecules with high affinity as well as specificity. However, the conventional process of aptamer…

Read More Brock Researchers Develop AI-Powered Tool ‘DAPTEV’ to Design New Aptamer Drugs for COVID-19
Bioinformatics | Biomedical Engineering | Corona Virus | COVID-19 | Covid-19 News | Health | Infectious Diseases | Machine Learning | News | Paper Summary | Trending

Scientists Introduce ‘GeNose C19’ a Quick Screening Tool for Sniffing Out COVID-19 Based on Exhaled Breath-print Recognition
ByTanveen Kaur August 19, 2022August 19, 2022

Universitas Gadjah Mada, Indonesia, scientists developed a low-cost, non-invasive method to rapidly sniff out COVID-19 by using an electronic nose named “GeNose C19”. The method of RT-qPCR, which stands for a reverse transcription-quantitative polymerase chain reaction, has been widely utilized to identify the SARS-CoV-2 virus that causes COVID-19. However, clinicians frequently prefer to use a…

Read More Scientists Introduce ‘GeNose C19’ a Quick Screening Tool for Sniffing Out COVID-19 Based on Exhaled Breath-print Recognition
Bioinformatics | Corona Virus | COVID-19 | Deep Learning | Drug Discovery | Health | Infectious Diseases | News | Paper Summary | Structural Biology | Trending

Hierarchical Structure-based Virtual Screening Targeting SARS-CoV-2 Endoribonuclease
BySrishti Sharma August 6, 2022October 22, 2026

Since the first appearance of SARS-CoV-2, a number of in silico methods have been employed to discover possible drugs that can target the viral life cycle. Scientists from National Research Centre, Egypt, targeted Endoribonuclease, which is one of the crucial non-structural proteins since it is responsible for processing viral RNA to escape detection by the…

Read More Hierarchical Structure-based Virtual Screening Targeting SARS-CoV-2 Endoribonuclease
Bioinformatics | Corona Virus | COVID-19 | Covid-19 News | Genomics | News | NGS | Paper Summary | Sequencing | Trending

Scientists Devised a Bioinformatics Method ‘COJAC’ for Early Detection and Surveillance of SARS-CoV-2 Genomic Variants in Wastewater
ByTanveen Kaur July 21, 2022November 11, 2022

Using read pairs with several SARS-CoV-2 variant-specific signature mutations as a reliable signal of low-frequency variants, scientists develop the bioinformatics technique known as COJAC (Co-Occurrence adjusted Analysis and Calling). The genomic sequencing, in conjunction with COJAC, can offer population-level estimates of the prevalence and fitness of emerging variants from wastewater samples earlier and on the basis…

Read More Scientists Devised a Bioinformatics Method ‘COJAC’ for Early Detection and Surveillance of SARS-CoV-2 Genomic Variants in Wastewater
Bioinformatics | Corona Virus | COVID-19 | Covid-19 News | News | Structural Biology | Trending

Contact Perturbation Analysis of the SARS-CoV-2 Delta Variant Singular Interface Dynamics
ByTanveen Kaur July 16, 2022November 11, 2022

Scientists demonstrate that L452R and T478K mutations in the Delta variant interact synergistically with nearby residues to cause significant alterations in the spike/ACE2 interface, suggesting a single mode of action. Understanding the molecular distinctions of emerging SARS-CoV-2 variants is essential because they raise questions about the capacity to endure the Covid-19 pandemic. Using crystallographic structures…

Read More Contact Perturbation Analysis of the SARS-CoV-2 Delta Variant Singular Interface Dynamics
Bioinformatics | Corona Virus | COVID-19 | Covid-19 News | Drug Discovery | News | Structural Biology | Trending

Scientists Develop Hybrid Molecules by Drug Repurposing in an Effort to Design New Drugs to Treat Covid-19
ByDr. Tamanna Anwar May 26, 2022October 22, 2026

Controlling the spread of the highly contagious disease and protecting human health requires developing new medications that stay effective against growing COVID-19 variations. After spending more than two years studying SARS-CoV-2, the virus that causes COVID-19, the researchers at the Department of Energy’s (DOE) Oak Ridge National Laboratory (ORNL) are designing and testing small-molecule antivirals…

Read More Scientists Develop Hybrid Molecules by Drug Repurposing in an Effort to Design New Drugs to Treat Covid-19
AI | Bioinformatics | Computational Models | Covid-19 News | Deep Learning | Machine Learning | Neural Network | News | Paper Summary | Structural Biology | Trending

A Novel Parallel Graph Neural Networks Based Method for Decoding Protein-Ligand Interactions
ByTanveen Kaur May 14, 2022November 9, 2022

A deep learning-based method for predicting the biophysical and biochemical features of protein-ligand complexes developed by researchers could help discover new drug candidates. Scientists formulate novel parallel graph neural networks for decoding protein-ligand interactions. This methodology can serve as an interpretable and explainable artificial intelligence (AI) tool for predicted activity, potency, and biophysical properties of…

Read More A Novel Parallel Graph Neural Networks Based Method for Decoding Protein-Ligand Interactions
Bioinformatics | Biotech | Corona Virus | COVID-19 | Covid-19 News | News | Trending

SARS-CoV-2 Delta Variant’s Unique Binding Leads to High Transmissibility
ByDr. Tamanna Anwar May 13, 2022June 18, 2022

The National Institutes of Health’s discovery could lead to new approaches to tackle future SARS-CoV-2 variants. According to a study by experts at the National Institutes of Health, unlike other SARS-CoV-2 variants, the Delta variant can bind to copies of itself, generating larger aggregations, or clumps, of virus particles. According to the researchers, this connecting…

Read More SARS-CoV-2 Delta Variant’s Unique Binding Leads to High Transmissibility
Bioinformatics | COVID-19 | Covid-19 News | Drug Discovery | News | Paper Summary

Scientists Revealed the Human Genetic Epidemiology of the COVID-19 Disease
ByTanveen Kaur May 12, 2022October 22, 2026

Scientists from the University of Helsinki, Broad Institute, and Harvard Medical School have revealed the human genetic epidemiology of the COVID-19 disease caused by SARS-CoV-2. The study indicates that the genetic association studies have been particularly fast in conveying new genetic signals underlying COVID-19 severity and disease susceptibility and can advance the treatment significantly. Human…

Read More Scientists Revealed the Human Genetic Epidemiology of the COVID-19 Disease
Bioinformatics | Corona Virus | COVID-19 | Covid-19 News | Drug Discovery

Repurposing FDA Approved Asthma Drug to Block Crucial SARS-CoV-2 Protein
ByDr. Tamanna Anwar May 2, 2022October 22, 2026

In a new study by scientists from the Indian Institute of Science (IISc), repurposing a drug used to treat asthma and allergies has been shown to bind and block a critical protein produced by the virus SARS-CoV-2, reducing viral replication in human immune cells. The US Food and Drug Administration (FDA) approved drug, montelukast, has…

Read More Repurposing FDA Approved Asthma Drug to Block Crucial SARS-CoV-2 Protein
AMR Alert | Antibiotic Resistance | COVID-19 | Covid-19 News | Drug Discovery | Paper Summary | Precision Medicine

Benefits and Challenges of ‘One-Size-Fits-All’ Anti-Tuberculosis Treatment Strategies
ByTanveen Kaur May 1, 2022October 22, 2026

An expert scientist affiliated with the Center for Discovery and Innovation and a colleague from Harvard T.H. Chan School of Public Health discussed the challenges and priorities in the anti-tuberculosis treatment strategies and drug development. The study published in Nature Reviews Microbiology this week suggests that the preclinical and clinical anti-tuberculosis treatment methodologies depicted in…

Read More Benefits and Challenges of ‘One-Size-Fits-All’ Anti-Tuberculosis Treatment Strategies
Bioinformatics | Corona Virus | Network Modeling | Structural Biology | Trending

Network Based Computer Modeling Revealed Omicron’s Mechanism of Escaping Antibodies
ByDr. Tamanna Anwar February 3, 2022June 18, 2022

According to a computational study carried out by researchers at MIT, several mutations in the virus’ spike protein enable it to dodge antibodies that target SARS-CoV-2. A new study published in the journal Cell Reports Medicine shows that the Omicron variant’s spike protein has dozens of mutations that let it elude all four types of…

Read More Network Based Computer Modeling Revealed Omicron’s Mechanism of Escaping Antibodies

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

SARS-CoV-2

Scientists Revealed the Human Genetic Epidemiology of the COVID-19 Disease

Repurposing FDA Approved Asthma Drug to Block Crucial SARS-CoV-2 Protein

Benefits and Challenges of ‘One-Size-Fits-All’ Anti-Tuberculosis Treatment Strategies

Training

Services

Resources

Company